News/ News/ R&D After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome Phil Taylor 9 Meters Biopharma, gastrointestinal, Gattex, short bowel syndrome, Takeda, vurolenatide 0 Comment Two weeks after reporting disappointing results for its lead coeliac disease therapy, 9 Meters Biopharma will draw some Share X After coeliac fail, 9 Meters plots phase 3 in short bowel syndrome https://pharmaphorum.com/news/after-coeliac-fail-9-meters-plots-phase-3-in-short-bowel-syndrome/